SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-18-000105
Filing Date
2018-08-07
Accepted
2018-08-07 17:22:48
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 6-30-2018 form10q.htm 10-Q 1770510
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 1327991
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 202849
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 12071
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 11911
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5759
  Complete submission text file 0000874015-18-000105.txt   11700301

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ions-20180630.xml EX-101.INS 2442578
8 XBRL TAXONOMY EXTENSION SCHEMA ions-20180630.xsd EX-101.SCH 69757
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20180630_cal.xml EX-101.CAL 67546
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20180630_def.xml EX-101.DEF 522680
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20180630_lab.xml EX-101.LAB 927154
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20180630_pre.xml EX-101.PRE 618943
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 18999149
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences